- Home
- CCBG vs VIR Comparison
CCBG vs VIR Comparison
Compare CCBG & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCBG
- VIR
- Stock Information
- Founded
- CCBG 1895
- VIR 2016
- Country
- CCBG United States
- VIR United States
- Employees
- CCBG N/A
- VIR N/A
- Industry
- CCBG Major Banks
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- CCBG Finance
- VIR Health Care
- Exchange
- CCBG Nasdaq
- VIR Nasdaq
- Market Cap
- CCBG 733.2M
- VIR 706.4M
- IPO Year
- CCBG N/A
- VIR 2019
- Fundamental
- Price
- CCBG $43.48
- VIR $5.27
- Analyst Decision
- CCBG Buy
- VIR Strong Buy
- Analyst Count
- CCBG 1
- VIR 10
- Target Price
- CCBG $45.00
- VIR $26.80
- AVG Volume (30 Days)
- CCBG 34.1K
- VIR 1.6M
- Earning Date
- CCBG 10-21-2025
- VIR 10-30-2025
- Dividend Yield
- CCBG 2.21%
- VIR N/A
- EPS Growth
- CCBG 14.00
- VIR N/A
- EPS
- CCBG 3.42
- VIR N/A
- Revenue
- CCBG $240,944,000.00
- VIR $19,000,000.00
- Revenue This Year
- CCBG $11.91
- VIR N/A
- Revenue Next Year
- CCBG $3.57
- VIR $9.65
- P/E Ratio
- CCBG $12.68
- VIR N/A
- Revenue Growth
- CCBG 8.96
- VIR N/A
- 52 Week Low
- CCBG $32.38
- VIR $4.16
- 52 Week High
- CCBG $44.69
- VIR $14.45
- Technical
- Relative Strength Index (RSI)
- CCBG 61.24
- VIR 57.10
- Support Level
- CCBG $42.96
- VIR $5.04
- Resistance Level
- CCBG $44.04
- VIR $5.64
- Average True Range (ATR)
- CCBG 0.86
- VIR 0.32
- MACD
- CCBG 0.15
- VIR 0.11
- Stochastic Oscillator
- CCBG 75.36
- VIR 64.97
About CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services among others through its banking offices in Florida, Georgia, and Alabama.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.